009300 — Sam-A Pharm Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩104bn
- KR₩48bn
- KR₩96bn
Annual cashflow statement for Sam-A Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 124 | 3,392 | 11,912 | 21,374 | 22,080 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 3,992 | 2,833 | 6,516 | 2,279 | 2,669 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1,401 | 3,019 | -2,010 | -6,788 | -3,767 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 9,408 | 12,943 | 19,604 | 20,760 | 25,247 |
| Capital Expenditures | -680 | -275 | -239 | -3,820 | -6,512 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 482 | -19,521 | -12,793 | -16,987 | -14,899 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -198 | -19,796 | -13,032 | -20,807 | -21,411 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3,665 | -3,670 | -5,381 | -112 | -3,522 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5,397 | -10,411 | 1,191 | -156 | 532 |